D. Penson

发表

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

A. D'Amico, J. McKenney, J. Eastham, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Epidemiology and cost of ventral hernia repair: making the case for hernia research

S. Phillips, M. Holzman, W. Nealon, 2012, Hernia.

Re: National Health Expenditure Projections, 2013-23: Faster Growth Expected with Expanded Coverage and Improving Economy.

D. Penson, 2015, Journal of Urology.

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

J. Stanford, D. Penson, A. Potosky, 2004, Journal of the National Cancer Institute.

Effect of injection augmentation on need for framework surgery in unilateral vocal fold paralysis

J. Netterville, D. Penson, Alexander H. Gelbard, 2016, The Laryngoscope.

Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation.

M. Cooperberg, S. Kaplan, S. Greenfield, 2020, European urology.

Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

P. Kantoff, P. Schellhammer, C. Redfern, 2010, The New England journal of medicine.

Twitter response to the United States Preventive Services Task Force recommendations against screening with prostate‐specific antigen

Ted Lee, Heather T Gold, Danil V Makarov, 2015, BJU international.

Combining longitudinal studies of PSA.

Lurdes Y T Inoue, Ruth Etzioni, Christopher Morrell, 2004, Biostatistics.

Internet Health Resources and the Cancer Patient

D. Penson, David F Penson, George J. Huang, 2008, Cancer investigation.

Early detection of prostate cancer: AUA Guideline.

Mohammad Hassan Murad, Michael J Barry, Peter C Albertsen, 2013, The Journal of urology.

Overdiagnosis and overtreatment of prostate cancer.

Ruth Etzioni, H Ballentine Carter, Ruth Etzioni, 2014, European urology.

Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts

Lurdes Y. T. Inoue, M. Cooperberg, P. Carroll, 2018, Annals of Internal Medicine.

Lessons learnt about early prostate cancer from large scale databases: population-based pearls of wisdom.

Peter C Albertsen, D. Penson, P. Albertsen, 2002, Surgical oncology.

Epidemiology of Vocal Fold Paralyses after Total Thyroidectomy for Well-Differentiated Thyroid Cancer in a Medicare Population

D. Penson, D. Francis, C. Garrett, 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Assessment of patient experience with unilateral vocal fold immobility: a preliminary study.

C Gaelyn Garrett, Barbara Jacobson, D. Penson, 2014, Journal of voice : official journal of the Voice Foundation.

Cancer in a Medicare Population Epidemiology of Vocal Fold Paralyses after Total Thyroidectomy for Well-Differentiated Thyroid

D. Penson, D. Francis, C. Garrett, 2014 .

Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

Peter H Gann, Eric J Feuer, Ruth Etzioni, 2002, Journal of the National Cancer Institute.

Impact of Adherence to Quality Measures for Localized Prostate Cancer on Patient-reported Health-related Quality of Life Outcomes, Patient Satisfaction, and Treatment-related Complications

S. Kaplan, S. Greenfield, S. Phillips, 2016, Medical care.

Assessing the Quality of Surgical Care for Clinically Localized Prostate Cancer: Results from the CEASAR Study.

M. Cooperberg, S. Kaplan, S. Greenfield, 2019, The Journal of urology.

Racial/Ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer.

J. Stanford, F. Gilliland, D. Penson, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Laparoscopic partial nephrectomy and prostatectomy: weighing the costs and the benefits.

D. Penson, 2004, The Journal of urology.

Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.

D. Penson, J. Stein, D. Skinner, 2009, The Journal of urology.

The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancer.

S. Ramsey, D. Penson, L. Clarke, 2005, The Journal of urology.

Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide?

S. Ramsey, D. Penson, L. Clarke, 2005, Urology.

Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer.

J. Stanford, M. Barry, D. Penson, 2013, Journal of the National Cancer Institute.

Cost-effectiveness of prostate cancer chemoprevention: A quality of life-years analysis

D. Penson, 2008 .

Re: Long Term Safety of Sacral Nerve Modulation in Medicare Beneficiaries.

D. Penson, 2016, The Journal of urology.

Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity

D. Penson, R. Dmochowski, P. Padmanabhan, 2011, World Journal of Urology.

What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models

Eveline A M Heijnsdijk, Harry J de Koning, Lurdes Y T Inoue, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Quality of life after sipuleucel-T therapy: results from a randomized, double-blind study in patients with androgen-dependent prostate cancer.

P. Schellhammer, D. Penson, L. M. Glodé, 2013, Urology.

Variations in prostate cancer patterns of care: is it the quality of care or the quality of the data?

D. Penson, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Re: Comparative effectiveness of skin antiseptic agents in reducing surgical site infections: a report from the Washington State Surgical Care and Outcomes Assessment Program.

D. Penson, 2014, The Journal of urology.

Trends in Treatment Costs for Localized Prostate Cancer: The Healthy Screenee Effect

Ruth Etzioni, S. Ramsey, D. Penson, 2007, Medical care.

Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

I. Thompson, P. Goodman, A. Kristal, 2008, American journal of epidemiology.

Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer.

Ruth Etzioni, I. Thompson, S. Ramsey, 2005, The American journal of medicine.

Steroid hormones and hormone-related genetic and lifestyle characteristics as risk factors for benign prostatic hyperplasia: review of epidemiologic literature.

A. Kristal, D. Penson, M. Neuhouser, 2004, Urology.

Obesity, physical activity and lower urinary tract symptoms: results from the Southern Community Cohort Study.

H. Munro, L. Signorello, W. Blot, 2011, The Journal of urology.

Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

I. Thompson, P. Goodman, A. Kristal, 2007, The Journal of urology.

Recent Changes in Prostate Cancer Screening Practices and Epidemiology

Daniel J. Lee, Sam S. Chang, D. Penson, 2017, The Journal of urology.

Comparison of the International Index of Erectile Function erectile domain scores and nocturnal penile tumescence and rigidity measurements: does one predict the other?

D. Penson, Claire C. Yang, Michael P. Porter, 2006, BJU international.

Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate Cancer

J. Beckman, D. Penson, L. Jones, 2016, Circulation.

Let's Not Throw the Baby out With the Bathwater in Prostate Cancer Screening.

D. Penson, M. Resnick, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Pendulum of Prostate Cancer Screening.

D. Penson, 2015, JAMA.

Letters to the Editor/Errata Re: Early Detection of Prostate Cancer: AUA guideline

Kirsten L. Greene, P. Kantoff, L. Holmberg, 2013 .

Mathematical Issues: PSA Testing

Ruth Etzioni, D. Penson, 2001 .

Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach.

T. D. de Reijke, E. Basch, T. Steuber, 2015, European urology.

Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy.

S. Phillips, Sam S. Chang, T. Morgan, 2011, The Journal of urology.

Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis

J. Concato, Ruth Etzioni, D. Penson, 2003, Cancer.

Long‐term outcome in patients with a Gleason score ≤6 prostate cancer treated by radical prostatectomy

S. Groshen, R. Cote, D. Penson, 2011, BJU international.

The economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: findings from a retrospective analysis of health plan data.

J. Moul, D. Penson, C. Evans, 2004, The Journal of urology.

Quantifying the role of PSA screening in the US prostate cancer mortality decline

Dante diTommaso, Seth Falcon, Angela Mariotto, 2008, Cancer Causes & Control.

Bone Complications Among Prostate Cancer Survivors: Long-Term Follow-Up From the Prostate Cancer Outcomes Study

J. Stanford, D. Penson, T. Koyama, 2014, Prostate Cancer and Prostatic Disease.

Variation in the Diagnostic Evaluation among Persons with Hematuria: Influence of Gender, Race and Risk Factors for Bladder Cancer

W. Blot, D. Penson, T. Koyama, 2017, The Journal of urology.

Influence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapy.

J. Stanford, D. Penson, T. Koyama, 2015, The Journal of urology.

Trends in the use of evidence‐based therapy for resectable gastric cancer

D. Penson, N. Merchant, T. Koyama, 2014, Journal of surgical oncology.

Association of Preexisting Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients.

S. Ramsey, D. Penson, S. K. Van Den Eeden, 2008, The patient.

Risks of Serious Toxicities from Intermittent versus Continuous Androgen Deprivation Therapy for Advanced Prostate Cancer: A Population Based Study

R. Pfeiffer, D. Penson, A. Fu, 2017, The Journal of urology.

Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients.

Sam S. Chang, T. Morgan, D. Penson, 2012, Urology.

Epidemiology of Stress Urinary Incontinence in Women

D. Penson, R. Dmochowski, W. Reynolds, 2011, Current urology reports.

Quality of life issues in bladder cancer patients following cystectomy and urinary diversion.

John T. Wei, D. Penson, M. Porter, 2005, The Urologic clinics of North America.

Epidemiological Studies Reporting Prevalence of ED

D. Penson, 2004 .

Erectile Dysfunction in Diabetic Patients

D. Penson, H. Wessells, 2004 .

The physical burden of prostate cancer.

D. Penson, M. Litwin, 2003, The Urologic clinics of North America.

Choledocholithiasis management in rural America: health disparity or health opportunity?

S. Phillips, M. Holzman, W. Nealon, 2011, The Journal of surgical research.

Laparoscopic urological oncology: here come the outcomes!

D. Penson, 2005, The Journal of urology.

Contemporary prostate cancer radiation therapy in the United States: Patterns of care and compliance with quality measures.

Daniel J. Lee, M. Cooperberg, S. Kaplan, 2018, Practical radiation oncology.

Prostate Cancer, Version 1.2016.

Christopher J Kane, Charles A Enke, James L Mohler, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Patient Reported Comparative Effectiveness of Contemporary Intensity Modulated Radiation Therapy Versus External Beam Radiation Therapy of the Mid 1990s for Localized Prostate Cancer

M. Cooperberg, S. Kaplan, S. Greenfield, 2017, Urology practice.

Osteoclast inhibitor treatment among men with metastatic castration-resistant prostate cancer

D. Penson, A. Morgans, A. Graves, 2018, Clinical oncology and research.

Comparison of open live donor nephrectomy, laparoscopic live donor nephrectomy, and hand-assisted live donor nephrectomy: a cost-minimization analysis.

B. Poulose, D. Penson, C. Pinson, 2012, The Journal of surgical research.

The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-based Cohort.

M. Cooperberg, S. Kaplan, S. Greenfield, 2017, Urology.

Assessing the quality of prostate cancer care

D. Penson, 2008, Current opinion in urology.

Determining cause of death in prostate cancer: are death certificates valid?

P. Nelson, J. Stanford, M. Barry, 2001, Journal of the National Cancer Institute.

The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.

M. Cooperberg, S. Kaplan, S. Greenfield, 2015, European urology.

Medicare Accountable Care Organization Enrollment and Appropriateness of Cancer Screening

Daniel J. Lee, M. Buntin, D. Penson, 2018, JAMA internal medicine.

The association between Medicare accountable care organization enrollment and breast, colorectal, and prostate cancer screening

M. Buntin, D. Penson, A. Graves, 2018, Cancer.

The more, the merrier: including a medical oncologist in treatment planning for localized prostate cancer.

D. Penson, A. Morgans, 2014, Journal of oncology practice.

Association between surgical volume and survival among patients with variant histologies of bladder cancer.

Mary E. Hall, Sam S. Chang, D. Penson, 2021, Urology.

Volume outcomes of cystectomy--is it the surgeon or the setting?

Sam S. Chang, T. Morgan, D. Penson, 2012, The Journal of urology.

Survivorship and improving quality of life in men with prostate cancer.

T. Skolarus, S. Boorjian, A. Briganti, 2015, European urology.

The Cancer Survival Query System: Making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patients

E. Feuer, A. Mariotto, B. Hankey, 2012, Cancer.

Socioeconomic factors, urological epidemiology and practice patterns.

D. Penson, 2008, The Journal of urology.

Re: Comparison of Gonadotropin-Releasing Hormone Agonists and Orchiectomy: Effects of Androgen-Deprivation Therapy.

D. Penson, 2016, The Journal of urology.

Re: Annual Medical Expenditure and Productivity Loss among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States.

D. Penson, 2016, The Journal of urology.

Predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project.

D. Penson, J. Stein, A. Hamilton, 2008, The Journal of urology.

Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer.

S. Ramsey, D. Penson, S. K. Van Den Eeden, 2012, Urology.

Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective survey.

S. Ramsey, D. Penson, S. K. Van Den Eeden, 2010, The Journal of urology.

Prostate cancer.

D. Penson, J. Chan, 2007, The Journal of urology.

Effect of the USPSTF Grade D Recommendation against Screening for Prostate Cancer on Incident Prostate Cancer Diagnoses in the United States.

Sam S. Chang, D. Penson, D. Winchester, 2015, The Journal of urology.

Re: Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.

D. Penson, 2016, The Journal of urology.

The Influence of Access Related Factors on Adherence to Clinical Practice Guidelines for Muscle Invasive Bladder Cancer

Sanjay G. Patel, Sam S. Chang, D. Penson, 2014, Urology practice.

Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.

P. Carroll, D. Penson, V. Master, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nationwide Trends inMastectomy for Early-Stage Breast Cancer

D. Penson, Y. Shyr, L. Du, 2015 .

Access to information sources and treatment considerations among men with local stage prostate cancer.

S. Ramsey, D. Penson, S. K. Van Den Eeden, 2009, Urology.

Longitudinal differences in psychological outcomes for men with erectile dysfunction: results from ExCEED.

D. Lubeck, D. Penson, T. Lue, 2006, The journal of sexual medicine.

The impact of hospital volume on short-term and long-term outcomes for patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma.

Sam S. Chang, D. Penson, A. Luckenbaugh, 2020, Urology.

Survival associated with treatment vs. observation of localized prostate cancer in elderly men

D. Penson, 2007 .

Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiences.

I. Thompson, C. Moinpour, S. Ramsey, 2013, The journal of sexual medicine.

Quality of life and satisfaction with outcome among prostate-cancer survivors

D. Penson, 2008 .

Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999.

Ruth Etzioni, S. Ramsey, D. Penson, 2004, Urology.

Use of prostate-specific antigen in the follow-up of patients with localized prostate cancer: results of a nationwide survey of urologists.

J. Moul, D. Penson, D. Newling, 2006, Urology.

Diffusion of surgical innovation among patients with kidney cancer

D. Penson, 2008 .

Re: Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.

D. Penson, 2017, The Journal of urology.

Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts

Jane M Lange, P. Carroll, B. Trock, 2020, Cancer.

Out-of-pocket costs for commercially insured patients with localized prostate cancer.

D. Penson, A. Luckenbaugh, S. Dusetzina, 2021, Urologic oncology.

Reply to I.E. Haines.

D. Penson, M. Resnick, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oncology: Prostate/Testis/Penis/Urethra Interpretation of Domain Scores on the EPICdHow Does the Domain Score Translate into Functional Outcomes?

M. Cooperberg, S. Kaplan, S. Greenfield, 2022 .

Physicians’ perspectives on the informational needs of low-risk prostate cancer patients

D. Penson, S. K. Van Den Eeden, D. Aaronson, 2017, Health education research.

Multiparametric magnetic resonance imaging (MRI) with targeted fusion biopsy: is the time now?

D. Penson, A. Laviana, 2018, BJU international.

The relationship between symptomatology and treatment selection in metastatic castrate-resistant prostate cancer.

D. Penson, E. Small, O. Sartor, 2011, Clinical advances in hematology & oncology : H&O.

‘Killing two birds with one stone’: patient‐reported quality‐of‐life outcomes from the Prostate Testing for Cancer and Treatment (ProtecT) trial

D. Penson, M. Tyson, 2016, BJU international.

Editorial Comment.

D. Penson, 2019, The Journal of urology.

Quality of Life Outcomes Following Treatment for Localized Prostate Cancer: What's New and What's Not.

D. Penson, 2017, European urology.

Re: A Comparison of Web-Based versus Print-Based Decision Aids for Prostate Cancer Screening: Participants' Evaluation and Utilization.

D. Penson, 2017, The Journal of urology.

Re: variation among primary care physicians in prostate-specific antigen screening of older men.

D. Penson, 2014, The Journal of urology.

Re: Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.

D. Penson, 2014, The Journal of urology.

Re: Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review.

D. Penson, 2013, The Journal of urology.

Doing More for More: Unintended Consequences of Financial Incentives for Oncology Specialty Care.

Sam S. Chang, D. Penson, B. O’Neil, 2016, Journal of the National Cancer Institute.

Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients

Angela Mariotto, Deborah Schrag, A. Mariotto, 2016, Medical care.

An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States.

E. Feuer, Ruth Etzioni, A. Mariotto, 2004, American journal of epidemiology.

Impact of PSA Screening on the Incidence of Advanced Stage Prostate Cancer in the United States: A Surveillance Modeling Approach

Seth Falcon, Ruth Etzioni, Roman Gulati, 2008, Medical decision making : an international journal of the Society for Medical Decision Making.

The relationship among lower urinary tract symptoms, prostate specific antigen and erectile dysfunction in men with benign prostatic hyperplasia: results from the proscar long-term efficacy and safety study.

D. Penson, S. Paick, H. Wessells, 2005, The Journal of urology.

Clinical research methods for surgeons

John T. Wei, L. Greenfield, D. Penson, 2007 .

Modeling economic and epidemiological impact of voluntary medical male circumcision among men who have sex with men in Beijing, China

S. Vermund, G. Webb, D. Penson, 2019, International journal of STD & AIDS.

Adrenal control of erectile function and nitric oxide synthase in the rat penis.

D. Penson, J. Rajfer, N. Gonzalez-Cadavid, 1997, Endocrinology.

Quality of life following prostate cancer treatments

D. Penson, 2000, Current urology reports.

Medicare reimbursement changes for bladder biopsies

D. Penson, 2010, Cancer.

The effect of erectile dysfunction on quality of life following treatment for localized prostate cancer.

D. Penson, 2001, Reviews in urology.

NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.

A. D'Amico, J. McKenney, J. Eastham, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer.

S. Phillips, Sam S. Chang, T. Morgan, 2013, Urologic oncology.

D. Penson, M. Porter, 2005, The Journal of urology.

Benchmarking patient satisfaction scores in a colorectal patient population

R. Baucom, D. Penson, R. Rothman, 2020, Surgical Endoscopy.

SOCIODEMOGRAPHIC AND CLINICAL RISK CHARACTERISTICS OF PATIENTS WITH PROSTATE CANCER WITHIN THE VETERANS AFFAIRS HEALTH CARE SYSTEM: DATA FROM C A PSURE

M. Cooperberg, D. Lubeck, S. Mehta, 2003 .

Cost-effective management of pelvic fracture urethral injuries

D. Penson, R. Dmochowski, W. Reynolds, 2017, World Journal of Urology.

The influence of provider characteristics and market forces on response to financial incentives.

Sam S. Chang, D. Penson, B. O’Neil, 2017, American Journal of Managed Care.

Trends in Care Delivery for Disorders of the Female Pelvic Floor

D. Penson, R. Dmochowski, W. Reynolds, 2012, Current Bladder Dysfunction Reports.

Ethical Issues in Clinical Research

D. Penson, 2006 .

Association Between Socioeconomic Status (SES) and Lower Urinary Tract Symptom (LUTS) Severity Among Black and White Men

H. Munro, L. Signorello, W. Blot, 2011, Journal of General Internal Medicine.

Oncologic Outcomes after Anterior Exenteration for Muscle Invasive Bladder Cancer in Women.

Sam S. Chang, D. Penson, Michael Cookson, 2016, The Journal of urology.

Re: Making Cuts to Medicare: The Views of Patients, Physicians, and the Public.

D. Penson, 2015, The Journal of urology.

Computer-generated graphical presentations: use of multimedia to enhance communication.

D. Penson, J. Dekernion, J. Maller, 1997, Urology.

Urinary retention and catheter use among U.S. female Medicare beneficiaries: Prevalence and risk factors

D. Penson, R. Dmochowski, W. Reynolds, 2017, Neurourology and urodynamics.

Urinary functional outcomes in female neobladder patients

D. Penson, S. Daneshmand, D. Skinner, 2014, World Journal of Urology.

Predicting the Probability of 90-day Survival in Elderly Bladder Cancer Patients Treated with Radical Cystectomy

Sam S. Chang, T. Morgan, D. Penson, 2019 .

Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease

S. Herrell, D. Penson, B. Park, 2022, Nature Communications.

Immediate effects of the initial FDA notification on the use of surgical mesh for pelvic organ prolapse surgery in medicare beneficiaries

D. Penson, R. Dmochowski, W. Reynolds, 2013, Neurourology and urodynamics.

PROSTATE CANCER DETECTION USING A NOVEL COMPUTERIZED THREE-DIMENSIONAL PROSTATE BIOPSY TEMPLATE (TARGETSCAN™): RESULTS OF A MULTICENTER PROSPECTIVE DATA REGISTRY

John T. Wei, A. Kibel, S. Taneja, 2009 .

Association between body mass index and localized prostate cancer management and disease‐specific quality of life

M. Cooperberg, S. Kaplan, S. Greenfield, 2022, BJUI compass.

Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer

M. Cooperberg, S. Kaplan, S. Greenfield, 2022, Prostate Cancer and Prostatic Diseases.

Surgeons’ Perspective of Decision Making in Recurrent Diverticulitis

S. Regenbogen, D. Penson, R. Rothman, 2022, Annals of surgery open : perspectives of surgical history, education, and clinical approaches.

COVID-19 and financial toxicity in patients with renal cell carcinoma

D. Penson, S. Pal, M. Staehler, 2020, World Journal of Urology.

Active surveillance: not your father's watchful waiting.

D. Penson, 2009, Oncology.

Re: Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.

D. Penson, 2012, The Journal of urology.

Re: Projecting the Urology Workforce over the Next 20 Years.

D. Penson, 2017, The Journal of urology.

What Do Men with Metastatic Prostate Cancer Consider When Making Treatment Decisions? A Mixed-methods Study

D. Penson, B. Gonzalez, A. Morgans, 2020, Patient preference and adherence.

PCN14 IS COMBINED ANDROGEN BLOCKADE WITH BICALUTAMIDE COST-EFFECTIVE COMPARED WITH COMBINED ANDROGEN BLOCKADE WITH FLUTAMIDE?

S. Ramsey, D. Penson, L. Clarke, 2005 .

Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic castration-resistant prostate cancer: PROSPER subgroup analysis by age and region

F. Saad, D. Penson, B. Tombal, 2021, European Journal of Cancer.

Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.

F. Saad, D. Penson, C. Sternberg, 2020, The New England journal of medicine.

Reply to M.A.N. Şendur et al and J. Michels.

N. Agarwal, C. Higano, D. Penson, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adoption of Intermittent Androgen Deprivation Therapy for Advanced Prostate Cancer: A Population Based Study in American Urology Practice

J. Lynch, D. Penson, H. Tsai, 2015, Urology practice.

Re: Bisphosphonate Prescriptions in Men with Androgen Deprivation Therapy Use.

D. Penson, 2015, The Journal of urology.

Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial

Sam S. Chang, D. Penson, Michael Cookson, 2019, The Journal of urology.

Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy.

Haerin Lee, Sam S. Chang, D. Penson, 2014, The Journal of urology.

Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter?

Sam S. Chang, T. Morgan, D. Penson, 2013, The Journal of urology.

ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion.

R. Hautmann, D. Penson, U. Studer, 2013, European urology.

Financial Toxicity Among Patients with Prostate, Bladder, and Kidney Cancer: A Systematic Review and Call to Action.

B. Gyawali, S. Psutka, D. Penson, 2021, European urology oncology.

Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database.

D. Lubeck, D. Penson, J. Henning, 2003, Diabetes care.

Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment

M. Cooperberg, S. Kaplan, S. Greenfield, 2014, Cancer.

Eosinophilic esophagitis: dilate or medicate? A cost analysis model of the choice of initial therapy.

D. Penson, M. Vaezi, R. Kavitt, 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Evaluation and Treatment of Cryptorchidism

D. Penson, M. McPheeters, S. Krishnaswami, 2012 .

Androgen and pituitary control of penile nitric oxide synthase and erectile function in the rat.

D. Penson, J. Rajfer, N. Gonzalez-Cadavid, 1996, Biology of reproduction.

Checklist to operationalize measurement characteristics of patient-reported outcome measures

D. Penson, M. McPheeters, I. Feurer, 2016, Systematic Reviews.

Update on AUA guideline on the management of benign prostatic hyperplasia.

John T. Wei, C. Roehrborn, M. Barry, 2011, The Journal of urology.

Effectiveness of Hormonal and Surgical Therapies for Cryptorchidism: A Systematic Review

D. Penson, M. McPheeters, S. Krishnaswami, 2013, Pediatrics.

Prevention of seminiferous tubular atrophy in a naturally cryptorchid rat model by early surgical intervention.

D. Penson, B. Petrie, A. Freedman, 1996, Journal of andrology.

The cost-effectiveness of treatment for varicocele related infertility.

H. Krumholz, D. Penson, A. Paltiel, 2002, The Journal of urology.

Effect of cryptorchidism on testicular histology in a naturally cryptorchid animal model.

D. Penson, A. Freedman, J. Rajfer, 1997, The Journal of urology.

Magnetic Resonance Imaging for Locating Nonpalpable Undescended Testicles: A Meta-analysis

D. Penson, C. Fonnesbeck, M. McPheeters, 2013, Pediatrics.

Magnetic Resonance Imaging for Locating Nonpalpable Undescended Testicles: A Meta-analysis abstract

D. Penson, C. Fonnesbeck, M. McPheeters, 2013 .

Patient-reported outcome measures in dysphagia: a systematic review of instrument development and validation.

Nila A. Sathe, D. Penson, N. Sathe, 2017, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Future Research Needs for Outcomes of Weight Gain in Pregnancy

Rebecca N. Jerome, D. Penson, R. Jerome, 2010 .

Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials

D. Penson, L. Klotz, S. Flanders, 2018, BMC Urology.

Evaluating localized prostate cancer and identifying candidates for focal therapy.

Mark A Rubin, Jonathan Coleman, Hedvig Hricak, 2008, Urology.

An update on randomized clinical trials in localized and locoregional prostate cancer.

D. Penson, 2005, Urologic oncology.

The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement.

Daniel E Spratt, Todd M Morgan, Samir S Taneja, 2019, European urology.

Nationwide trends in mastectomy for early-stage breast cancer.

Yu Shyr, D. Penson, Y. Shyr, 2015, JAMA surgery.

Su1137 Dilate or Medicate? a Decision Analysis of Initial Treatment Strategies in Eosinophilic Esophagitis

D. Penson, M. Vaezi, R. Kavitt, 2012 .

General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study.

J. Stanford, F. Gilliland, Ziding Feng, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.

S. Herrell, Sam S. Chang, D. Penson, 2017, Urologic oncology.

Pelvic organ prolapse (POP) surgery: the evidence for the repairs

D. Penson, R. Dmochowski, A. Gomelsky, 2011, BJU international.

Prostate cancer and the Will Rogers phenomenon.

James A Hanley, Peter C Albertsen, J. Hanley, 2005, Journal of the National Cancer Institute.

American Urological Association ( AUA ) Guideline EARLY DETECTION OF PROSTATE CANCER : AUA GUIDELINE

Kirsten L. Greene, P. Kantoff, L. Holmberg, 2018 .

Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial.

F. Saad, D. Penson, B. Tombal, 2019, The Lancet. Oncology.

A Clinician’s Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III)

E. Crawford, S. Freedland, A. Ross, 2019, The Journal of urology.

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

P. Kantoff, M. Cooperberg, T. Rebbeck, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

N. Aaronson, D. Penson, M. Litwin, 2003, The Journal of urology.

Adverse effects of androgen deprivation therapy and strategies to mitigate them.

A. D'Amico, P. Kantoff, N. Keating, 2015, European urology.

Enzalutamide versus bicalutamide in patients with nonmetastatic castration-resistant prostate cancer: a prespecified subgroup analysis of the STRIVE trial

G. Haas, N. Agarwal, A. Armstrong, 2021, Prostate cancer and prostatic diseases.

Why do men choose one treatment over another?

S. Ramsey, D. Penson, D. Ekwueme, 2006, Cancer.

Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial.

N. Agarwal, A. Armstrong, C. Higano, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study.

Ziding Feng, Dale McLerran, Peter C Albertsen, 2005, The Journal of urology.

Prostate Cancer Registries: Current Status and Future Directions.

David C. Miller, M. Cooperberg, F. Bray, 2016, European urology.

Castration-resistant prostate cancer: AUA Guideline.

W. Lowrance, A. Kibel, W. Oh, 2013, The Journal of urology.

Final overall survival (OS) from PROSPER: A phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) in men with nonmetastatic castration-resistant prostate cancer (nmCRPC).

F. Saad, D. Penson, C. Sternberg, 2020 .

Symptoms and inflammation in chronic prostatitis/chronic pelvic pain syndrome.

D. Penson, J. Krieger, D. Riley, 2002, Urology.

The hemodynamic pathophysiology of impotence following blunt trauma to the erect penis.

D. Frohrib, I. Goldstein, D. Penson, 1992, The Journal of urology.

PII-LBA10 A MULTICENTER PHASE 2 STUDY OF ENZALUTAMIDE (ENZA) VERSUS BICALUTAMIDE (BIC) IN MEN WITH NONMETASTATIC (M0) OR METASTATIC (M1) CASTRATION-RESISTANT PROSTATE CANCER (CRPC): THE STRIVE TRIAL

N. Agarwal, A. Armstrong, C. Higano, 2015 .

Pharmacoeconomics of Available Treatment Options for Metastatic Prostate Cancer

D. Penson, S. Zeliadt, 2012, PharmacoEconomics.

Prostate cancer: Quality of life after radiation and androgen deprivation

D. Penson, D. Makarov, 2009, Nature Reviews Urology.

Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer.

Ruth Etzioni, D. Penson, A. Potosky, 2006, International journal of radiation oncology, biology, physics.

Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years

M. Cooperberg, S. Kaplan, S. Greenfield, 2017, JAMA.

Prediction of long-term other-cause mortality in men with early-stage prostate cancer: results from the Prostate Cancer Outcomes Study.

J. Stanford, T. Daskivich, D. Penson, 2015, Urology.

Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study

J. Stanford, M. Barry, T. Daskivich, 2015, Journal of General Internal Medicine.

Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study.

M. Cooperberg, S. Kaplan, S. Greenfield, 2013, Journal of comparative effectiveness research.

Capsule Commentary on Shahinian et al.: Patterns of Bone Mineral Density Testing in Men Receiving Androgen Deprivation for Prostate Cancer

D. Penson, 2013, Journal of general internal medicine.

Effect of Age, Tumor Risk, and Comorbidity on Competing Risks for Survival in a U.S. Population–Based Cohort of Men With Prostate Cancer

Michael Goodman, Kang-Hsien Fan, Tatsuki Koyama, 2013, Annals of Internal Medicine.

Factors influencing patients' acceptance and adherence to active surveillance.

D. Penson, 2012, Journal of the National Cancer Institute. Monographs.

How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor.

James M Henning, D. Lubeck, P. Carroll, 2002, The Journal of urology.

The comparative oncologic effectiveness of available management strategies for clinically localized prostate cancer.

D. Penson, M. Resnick, M. Tyson, 2017, Urologic oncology.

The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples.

M. Cooperberg, S. Kaplan, S. Greenfield, 2016, The Journal of urology.

The Impact of Health Literacy on Surgical Outcomes Following Radical Cystectomy

S. Kripalani, Sam S. Chang, D. Penson, 2016, Journal of health communication.

Quality of Life Measures

D. Penson, C. Anderson, D. Barocas, 2015 .

Psychometric characteristics of a condition-specific, health-related quality-of-life survey: the FACT-Vanderbilt Cystectomy Index.

D. Penson, Michael Cookson, G. Steinberg, 2012, Urology.

Urinary diversion: how experts divert.

R. Hautmann, D. Penson, U. Studer, 2015, Urology.

Radiotherapy after radical prostatectomy: Effect of timing of postprostatectomy radiation on functional outcomes.

M. Cooperberg, S. Kaplan, S. Greenfield, 2020, Urologic oncology.

Decision‐making processes among men with low‐risk prostate cancer: A survey study

D. Penson, S. K. Van Den Eeden, A. Leimpeter, 2018, Psycho-oncology.

Current Perspective on Adverse Effects in Shock Wave Lithotripsy

J. Lingeman, A. Evan, J. Mcateer, 2009 .

Increasing use of observation among men at low risk for prostate cancer mortality.

Sam S. Chang, D. Penson, C. Ritch, 2015, The Journal of urology.

Quality of life after breast cancer diagnosis and survival.

Kai Gu, Wei Lu, Wei Zheng, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Knowledge of the harms of tobacco use among patients with bladder cancer

J. Gore, D. Penson, W. McCarthy, 2014, Cancer.

Segmental testicular infarction in the neonate: a case report.

W. Aronson, D. Penson, 1995, The Journal of urology.

Provider and partner interactions in the treatment decision‐making process for newly diagnosed localized prostate cancer

I. Thompson, C. Moinpour, S. Ramsey, 2011, BJU international.

5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study.

J. Stanford, F. Gilliland, Ziding Feng, 2008, The Journal of urology.

Real‐world outcomes of sipuleucel‐T treatment in PROCEED, a prospective registry of men with metastatic castration‐resistant prostate cancer

Hong Tang, Matthew R Cooperberg, Andrew J Armstrong, 2019, Cancer.

Surgeon Participation in Early Accountable Care Organizations

Michael R Richards, M. Buntin, D. Penson, 2017, Annals of surgery.

Renal cell cancer histological subtype distribution differs by race and sex

S. Herrell, Sam S. Chang, D. Penson, 2016, BJU international.

Cardiology Patient Page. ABCDE Steps for Heart and Vascular Wellness Following a Prostate Cancer Diagnosis.

M. Allaf, D. Penson, L. Jones, 2015, Circulation.

National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats.

Sanjay G Patel, Sanjay G. Patel, S Duke Herrell, 2012, The Journal of urology.

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry

P. Kantoff, M. Cooperberg, P. Schellhammer, 2020, Prostate Cancer and Prostatic Diseases.

Invasive T1 bladder cancer: indications and rationale for radical cystectomy

D. Penson, J. Stein, 2008, BJU international.

The effect of health insurance status on the treatment and outcomes of patients with colorectal cancer

A. Parikh, D. Penson, V. Zaydfudim, 2014, Journal of surgical oncology.

Predictors of Response Outcomes for Research Recruitment Through a Central Cancer Registry: Evidence From 17 Recruitment Efforts for Population-Based Studies.

Morgan M. Millar, N. Camp, L. Cannon-Albright, 2019, American journal of epidemiology.

Prostate-specific antigen and free prostate-specific antigen in the early detection of prostate cancer: do combination tests improve detection?

S. Falcon, C. Kooperberg, Ruth Etzioni, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.

Samir S Taneja, Paul Schellhammer, H Ballentine Carter, 2013, The Journal of urology.

AUA/Optimal Techniques of Prostate Biopsy and Specimen Handling

P. Schellhammer, S. Taneja, D. Troyer, 2013 .

Long-term functional outcomes after treatment for localized prostate cancer.

J. Stanford, D. Penson, T. Koyama, 2013, The New England journal of medicine.

The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population.

C. Gross, D. Penson, D. Makarov, 2012, The Journal of urology.

Therapeutic Ultrasound and Prostate Cancer

Sam S. Chang, D. Penson, S. Arora, 2017, Seminars in Interventional Radiology.

Trends in the treatment of localized prostate cancer using supplemented cancer registry data

D. Penson, D. Deapen, A. Hamilton, 2011, BJU international.

Prostate cancer survivorship care guideline: American Society of Clinical Oncology Clinical Practice Guideline endorsement.

K. Hoffman, D. Penson, A. Morgans, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Re: Risk of fracture after radical cystectomy and urinary diversion for bladder cancer.

D. Penson, 2015, The Journal of urology.

Association between race and follow‐up diagnostic care after a positive prostate cancer screening test in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial

E. Crawford, G. Andriole, D. Penson, 2013, Cancer.

Chapter 6 – Health-Related Quality of Life Issues in Urologic Oncology

D. Penson, M. Litwin, 2005 .

Racial variation in the quality of surgical care for bladder cancer

Sam S. Chang, D. Penson, Michael Cookson, 2014, Cancer.

Phase III Prevention Trial of Fenretinide in Patients with Resected Non–Muscle-Invasive Bladder Cancer

A. Sabichi, H. Parnes, S. Lippman, 2008, Clinical Cancer Research.

Phase III PreventionTrial of Fenretinide in Patients with Resected Non ^ Muscle-Invasive Bladder Cancer

A. Sabichi, H. Parnes, S. Lippman, 2007 .

Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.

D. Penson, J. Stein, D. Skinner, 2008, The Journal of urology.

Sexual dysfunction and symptom impact in men with long-standing type 1 diabetes in the DCCT/EDIC cohort.

D. Penson, P. Cleary, H. Wessells, 2009, The journal of sexual medicine.

Characterizing Standardized Letters of Recommendation in Urology Residency Applications.

D. Penson, B. Breyer, L. Hampson, 2021, Urology.

Chapter 28 – Vasculogenic Erectile Dysfunction

D. Penson, K. Keegan, 2013 .

ORIGINAL RESEARCH—ERECTILE DYSFUNCTION: Clinical and Psychosocial Characteristics of Men with Erectile Dysfunction: Baseline Data from ExCEED™

D. Lubeck, D. Penson, T. Lue, 2006 .

Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes.

D. Penson, J. Lachin, P. Cleary, 2011, The Journal of urology.

Cross‐sectional and longitudinal comparisons of health‐related quality of life between patients with prostate carcinoma and matched controls

D. Penson, A. Potosky, W. Hunt, 2004, Cancer.

UC San Francisco UC San Francisco Previously Published Works Title Contemporary prevalence of pretreatment urinary , sexual , hormonal , and bowel dysfunction : Defining the population at risk for harms of prostate cancer treatment

M. Cooperberg, S. Kaplan, S. Greenfield, 2014 .

Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer.

S. Groshen, D. Penson, J. Stein, 2007, The Journal of urology.

Clinical trials in urology

D. Penson, C. Scales, 2018, Evidence-Based Urology.

D. Penson, George J. Huang, N. Sadetsky, 2010, The Journal of urology.

Patient-Reported Outcome Measures in Upper Airway–Related Dyspnea: A Systematic Review

Nila A. Sathe, D. Penson, N. Sathe, 2017, JAMA otolaryngology-- head & neck surgery.

Nila A. Sathe, D. Penson, N. Sathe, 2017, Journal of speech, language, and hearing research : JSLHR.

Hospital-Physician Consolidation Accelerated In The Past Decade In Cardiology, Oncology.

Michael R Richards, D. Penson, S. Nikpay, 2018, Health affairs.

Appropriate and inappropriate imaging rates for prostate cancer go hand in hand by region, as if set by thermostat.

C. Gross, H. Krumholz, D. Penson, 2012, Health affairs.

Urinary functional outcome following radical cystoprostatectomy and ileal neobladder reconstruction in male patients.

D. Penson, S. Daneshmand, E. Skinner, 2013, The Journal of urology.

Obesity, body composition, and prostate cancer

D. Penson, D. Barocas, S. Motley, 2012, BMC Cancer.

Insulin‐like growth factor‐I, insulin‐like growth factor binding protein‐3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial

I. Thompson, P. Goodman, C. Tangen, 2008, The Prostate.

Cigarette smoking and risk of prostate cancer in middle-aged men.

L. A. Plaskon, Janet L Stanford, J. Stanford, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Cigarette Smoking and Risk of Prostate Cancer in Middle-Aged Men 1

L. A. Plaskon, J. Stanford, D. Penson, 2003 .

Physician Performance Measurement Set

S. Edge, L. Potters, C. Cleeland, 2008 .

755 URINARY FUNCTION EVALUATION IN FEMALE CYSTECTOMY PATIENTS WITH ORTHOTOPIC DIVERSION UTILISING A VALIDATED HEALTH-RELATED QUALITY OF LIFE QUESTIONAIRE

D. Penson, S. Boyd, A. Schuckman, 2010 .

The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer.

D. Lubeck, D. Penson, M. Litwin, 2001, Journal of clinical epidemiology.

Validation of increasing prostate specific antigen as a predictor of prostate cancer death after treatment of localized prostate cancer with surgery or radiation.

J. Hanley, D. Penson, P. Albertsen, 2004, Journal of Urology.

The prevention of extraction site incisional hernia after robotic-assisted radical prostatectomy

Sam S. Chang, D. Penson, A. Luckenbaugh, 2021, Journal of Robotic Surgery.

Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE.

M. Cooperberg, D. Lubeck, S. Mehta, 2003, The Journal of urology.

The prostate cancer conundrum revisited

E. Feuer, H. D. de Koning, Ruth Etzioni, 2012, Cancer.

Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial.

Ruth Etzioni, I. Thompson, P. Goodman, 2005, The Journal of urology.

Patient-Reported Outcome Measures Related to Laryngopharyngeal Reflux

D. Penson, N. Sathe, M. McPheeters, 2016, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort.

James A Hanley, Peter C Albertsen, J. Hanley, 2007, The Journal of urology.

Racial variation in the incidence of squamous cell carcinoma of the bladder in the United States.

D. Penson, N. Weiss, L. Voigt, 2002, The Journal of urology.

Review Article HEALTH RELATED QUALITY OF LIFE IN MEN WITH PROSTATE CANCER

N. Aaronson, D. Penson, M. Litwin, 2003 .

Short term complications from transurethral resection of bladder tumor.

Sam S. Chang, D. Penson, Michael Cookson, 2016, The Canadian journal of urology.

Effect of Age, Tumor Risk, and Comorbidity in a U.S. Population–Based Cohort of Men With Prostate Cancer

T. Daskivich, D. Penson, M. Litwin, 2013, Annals of Internal Medicine.

Patient Recruitment Methods to Evaluate Treatment Decision Making for Localized Prostate Cancer

S. Ramsey, D. Penson, S. K. Van Den Eeden, 2010, American journal of clinical oncology.

Patient-Reported Outcome Measures in Colon and Rectal Surgery: A Systematic Review and Quality Assessment

D. Penson, R. Rothman, J. Canedo, 2020, Diseases of the colon and rectum.

Prostate cancer: epidemiology and health-related quality of life.

P. Scardino, D. Penson, M. Rossignol, 2008, Urology.

Reply to Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data

P. Kantoff, M. Cooperberg, A. Armstrong, 2020, Cancer.

A randomized trial of a specialist palliative care intervention for patients undergoing surgery for cancer: rationale and design of the Surgery for Cancer with Option of Palliative Care Expert (SCOPE) Trial

D. Penson, E. Ely, L. Beskow, 2019, Trials.

The Impact of Prostate Cancer Diagnosis and Post-treatment Sexual Dysfunction on Quality of Life

D. Penson, C. Nelson, 2009 .

The effectiveness of screening for prostate cancer: a nested case-control study.

J. Concato, C. Wells, D. Berlowitz, 2006, Archives of internal medicine.

The Effectiveness of Screening for Prostate Cancer

J. Concato, C. Wells, P. Peduzzi, 2002 .

Comparative effectiveness research in localized prostate cancer treatment.

M. Barry, A. Zietman, D. Penson, 2013, Journal of comparative effectiveness research.

28: The Cost-Effectiveness of Combined Androgen Blockade with Bicalutamide and LHRH Agonist in Men with Stage D2 Prostate Cancer

S. Ramsey, D. Penson, L. Clarke, 2005 .

Re: The Correlation of Media Ranking’s “Best” Hospitals and Surgical Outcomes following Radical Cystectomy for Urothelial Cancer

D. Penson, 2015 .

Adverse Events Associated with Cumulative Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims Analysis

D. Penson, K. Ramaswamy, Yan Song, 2020, Drug Safety.

Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results.

Daniel J. Lee, M. Cooperberg, S. Greenfield, 2018, European urology.

Treatment Decision Regret Among Long-Term Survivors of Localized Prostate Cancer: Results From the Prostate Cancer Outcomes Study.

J. Stanford, M. Barry, D. Penson, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience.

S. Herrell, Sam S. Chang, S. Kaffenberger, 2012, The Journal of urology.

Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer

J. Bomers, J. Fütterer, M. Haider, 2021, Journal of Urology.

Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.

M. Cooperberg, S. Kaplan, S. Greenfield, 2020, JAMA.

Assessing Quality of Life

D. Penson, M. Litwin, 2000 .

Patient-Reported Financial Toxicity Associated with Contemporary Treatment for Localized Prostate Cancer.

M. Cooperberg, S. Kaplan, S. Greenfield, 2020, The Journal of urology.

Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.

S. Groshen, D. Penson, J. Stein, 2006, The Journal of urology.

Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer.

M. Cooperberg, S. Kaplan, S. Greenfield, 2021, JAMA oncology.

National Variation in Elective Colon Resection for Diverticular Disease

Lauren R. Samuels, D. Penson, R. Rothman, 2020, Annals of surgery.

Trial Design Issues in the Study of Focal Therapy in Prostate and Kidney Cancer

D. Penson, J. Eifler, 2017 .

Male Sexual Function: A Guide to Clinical Management

D. Penson, 2002 .

Differences in health‐related quality of life of prostate cancer patients based on stage of cancer

D. Penson, B. Rosenfeld, A. Roth, 2004, Psycho-oncology.

Erectile aid use by men treated for localized prostate cancer.

J. Gore, D. Penson, M. Litwin, 2009, The Journal of urology.

Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer

D. Penson, S. K. Van Den Eeden, A. Leimpeter, 2019, Medical decision making : an international journal of the Society for Medical Decision Making.

Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modulated Radiotherapy, and Proton Beam Therapy.

Jim C Hu, S. Bhayani, D. Penson, 2017, European urology.

Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external-beam radiotherapy for prostate cancer: An assessment of the comparative effectiveness analysis of surgery and radiation (CEASAR) cohort.

M. Cooperberg, S. Kaplan, S. Greenfield, 2021, Urologic oncology.

Association of Pre-Existing Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients

S. Ramsey, D. Penson, S. Eeden, 2008 .

Quality of life with advanced metastatic prostate cancer.

D. Penson, M. Resnick, 2012, The Urologic clinics of North America.

Re: urologists' use of intensity-modulated radiation therapy for prostate cancer.

D. Penson, 2014, The Journal of urology.

Quality of Life After Therapy for Localized Prostate Cancer

D. Penson, 2007, Cancer journal.

Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes study.

D. Penson, M. Mori, Hong Li, 2007, The Journal of urology.

Insulin-LikeGrowth Factor-I, Insulin-LikeGrowth FactorBinding Protein-3 andRiskof Benign Prostate Hyperplasia in the ProstateCancer PreventionTrial

I. Thompson, P. Goodman, C. Tangen, 2008 .

Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials

D. Penson, L. Klotz, S. Flanders, 2018, BMC Urology.

Accountable care organizations in surgery: location, location, location: Comment on "will accountable care organizations cut costs and improve quality for inpatient surgery?".

D. Penson, 2013, JAMA surgery.

The Association Between Diffusion of the Surgical Robot and Radical Prostatectomy Rates

Cary P Gross, Danil V Makarov, James B Yu, 2011, Medical care.

Association between health-related quality of life (HRQoL) and clinical outcomes in non-metastatic castration-resistant prostate cancer (M0 CRPC): Results from the PROSPER study.

F. Saad, D. Penson, B. Tombal, 2018 .

Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia.

Tara K. Knight, D. Penson, M. Nichol, 2009, The Journal of urology.

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry

P. Kantoff, M. Cooperberg, P. Schellhammer, 2020, Prostate Cancer and Prostatic Diseases.

The politics of prostate cancer screening.

S. Kaffenberger, D. Penson, 2014, The Urologic clinics of North America.

The Polit ics of Prostate Cancer Screening

S. Kaffenberger, D. Penson, 2022 .

Gender, Race, and Variation in the Evaluation of Microscopic Hematuria Among Medicare Beneficiaries

D. Penson, T. Koyama, D. Barocas, 2015, Journal of General Internal Medicine.

Variation in the intensity of hematuria evaluation: a target for primary care quality improvement.

D. Penson, D. Barocas, D. Friedlander, 2014, The American journal of medicine.

913: Results of a Randomized Chemoprevention Trial with Fenretinide in Non-Muscle Invasive Bladder Cancer

A. Sabichi, S. Lippman, C. Dinney, 2005 .

The invasive T1 bladder tumor: Contemporary issues and rationale for radical cystectomy

D. Penson, J. Stein, 2008, Current urology reports.

Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy

Sam S. Chang, T. Morgan, D. Penson, 2014, BJU international.

Title Prostate Cancer Registries : Current Status and Future Directions Permalink

David C. Miller, M. Cooperberg, F. Bray, 2016 .

Prostate-sparing cystectomy: a review of the oncologic and functional outcomes. Contraindicated in patients with bladder cancer.

R. Hautmann, D. Penson, J. Stein, 2009, Urologic oncology.

Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer.

S. Herrell, S. Phillips, Sam S. Chang, 2011, The Journal of urology.

Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature.

D. Penson, J. Stein, D. Skinner, 2007, The Journal of urology.

Regional variation in total cost per radical prostatectomy in the healthcare cost and utilization project nationwide inpatient sample database.

C. Gross, A. Landman, D. Penson, 2010, The Journal of urology.

The Impact of Gender on Use of Pelvic Lymphadenectomy at the Time of Radical Cystectomy

D. Penson, T. Koyama, C. Anderson, 2014, Urology practice.

Re: Trends in Management for Patients with Localized Prostate Cancer, 1990-2013.

D. Penson, 2016, The Journal of urology.

Prostate Cancer Screening and the Goldilocks Principle: How Much Is Just Right?

T. Morgan, D. Penson, J. Simons, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of intermittent androgen deprivation therapy vs conventional continuous androgen deprivation therapy for advanced prostate cancer: a meta-analysis.

Huei-Ting Tsai, J. Lynch, D. Penson, 2013, Urology.

Quality of life after treatment for prostate cancer

D. Penson, M. Litwin, 2003, Current urology reports.

Quality of life in patients with localized prostate cancer.

D. Penson, M. Quek, 2005, Urologic oncology.

Seminar article Quality of life in patients with localized prostate cancer

D. Penson, M. Quek, 2005 .

Quality of life after treatment for prostate cancer

D. Penson, M. Litwin, 2003 .

General Q uality o f L ife 2 Y ears F ollowing T reatment f or Prostate C ancer: W hat I nfluences O utcomes? R esults F rom t he Prostate C ancer O utcomes S tudy

J. Stanford, F. Gilliland, Ziding Feng, 2003 .

Information Seeking and Satisfaction with Information Sources Among Spouses of Men with Newly Diagnosed Local-Stage Prostate Cancer

S. Ramsey, D. Penson, J. L. Smith, 2018, Journal of Cancer Education.

Out-of-Pocket Cost Burden Associated With Contemporary Management of Advanced Prostate Cancer Among Commercially Insured Patients

S. Boorjian, Vidit Sharma, D. Penson, 2022, The Journal of urology.

Health care reform 2010: a fresh view on tort reform.

D. Penson, R. Dmochowski, C. Stimson, 2010, The Journal of urology.

Obesity, body composition, and prostate cancer

D. Penson, D. Barocas, S. Motley, 2012, BMC Cancer.

Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE)

Sara J Knight, Janet E Cowan, D. Penson, 2013, BJU international.

Willingness to pay for prostate cancer treatment among patients and their family members at 1 year after diagnosis.

I. Thompson, C. Moinpour, S. Ramsey, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer

Sam S. Chang, D. Penson, D. Barocas, 2017, JAMA surgery.

The Effect of Nerve Sparing Status on Sexual and Urinary Function: 3‐Year Results from the CEASAR Study

Daniel J. Lee, M. Cooperberg, S. Greenfield, 2017, The Journal of urology.

Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap

D. Penson, D. Barocas, 2010, BJU international.

Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database.

P. Carroll, D. Penson, M. Litwin, 2001, Urology.

Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data.

Jack Hadley, Christopher S Saigal, D. Penson, 2010, Journal of the National Cancer Institute.

A comparison of general, genitourinary, bowel, and sexual quality of life among long term survivors of prostate, bladder, colorectal, and lung cancer.

I. Thompson, S. Ramsey, D. Penson, 2020, Journal of geriatric oncology.

Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer.

S. Herrell, Sam S. Chang, D. Penson, 2014, Urology.

Age at surgery for undescended testis and risk of testicular cancer

D. Penson, 2007 .

Longitudinal differences in disease specific quality of life in men with erectile dysfunction: results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction study.

D. Lubeck, D. Penson, J. Henning, 2003, The Journal of urology.

Is quality of life different for men with erectile dysfunction and prostate cancer compared to men with erectile dysfunction due to other causes? Results from the ExCEED data base.

D. Lubeck, D. Penson, J. Henning, 2003, The Journal of urology.

Psychological impact of erectile dysfunction: validation of a new health related quality of life measure for patients with erectile dysfunction.

D. Lubeck, S. Mehta, D. Penson, 2002, The Journal of urology.

On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer.

Scott D Ramsey, S. Ramsey, D. Penson, 2007, The Journal of urology.

D. Lubeck, P. Carroll, D. Penson, 2001, The Journal of urology.

Re: Active surveillance for prostate cancer compared with immediate treatment: an economic analysis.

D. Penson, 2013, The Journal of urology.

Re: use of statins and the risk of death in patients with prostate cancer.

S. Taneja, D. Penson, 2014, The Journal of urology.

Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer.

J. Morrow, Sam S. Chang, D. Penson, 2011, The Journal of urology.

Trends in the Multimodality Treatment of Resectable Colorectal Liver Metastases: an Underutilized Strategy

T. Pawlik, A. Parikh, D. Penson, 2013, Journal of Gastrointestinal Surgery.

The Patient Protection and Affordable Care Act: the impact on urologic cancer care.

D. Penson, K. Keegan, 2013, Urologic oncology.

Outcomes session.

S. Greenfield, D. Penson, M. Sanda, 2012, Urologic oncology.

Re: Long-term effect of hospital pay for performance on mortality in England.

D. Penson, 2015, Journal of Urology.

THE INFLUENCE OF PSYCHOSOCIAL CONSTRUCTS ON THE ADHERENCE TO ACTIVE SURVEILLANCE FOR LOCALIZED PROSTATE CANCER IN A PROSPECTIVE, POPULATION‐BASED COHORT: PD28‐04

M. Cooperberg, K. Hoffman, D. Penson, 2017 .

Benchmarking the use of a rapid response team by surgical services at a tertiary care hospital.

Jesse M. Ehrenfeld, D. Penson, R. Dmochowski, 2014, Journal of the American College of Surgeons.

Active Surveillance for Prostate Cancer under the Patient Protection and Affordable Care Act

D. Penson, M. Dall’Era, C. Evans, 2015, Urology practice.

Five‐year outcomes from a prospective comparative effectiveness study evaluating external‐beam radiotherapy with or without low‐dose‐rate brachytherapy boost for localized prostate cancer

M. Cooperberg, S. Kaplan, S. Greenfield, 2021, Cancer.

A 22 Gene-expression Assay, Decipher® (GenomeDx Biosciences) to Predict Five-year Risk of Metastatic Prostate Cancer in Men Treated with Radical Prostatectomy

D. Penson, A. Freedman, A. Potosky, 2015, PLoS currents.

Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes

M. Cooperberg, S. Kaplan, S. Greenfield, 2022, The Journal of urology.

Re: Dropout in the treatment of erectile dysfunction with PDE5: a study on predictors and a qualitative analysis of reasons for discontinuation.

D. Penson, 2013, The Journal of urology.

Re: Overweight Men with Nonobstructive Azoospermia Have Worse Pregnancy Outcomes after Microdissection Testicular Sperm Extraction

D. Penson, 2013 .

Re: association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.

D. Penson, A. Seftel, 2014, The Journal of urology.

8: Predictors of HRQOL Duirng Long-Term Follow-Up of Men Treated for Prostate Cancer

P. Carroll, D. Penson, George J. Huang, 2007 .

Early prostate cancer: prevention, treatment modalities, and quality of life issues.

J. Moul, D. Penson, L. Klotz, 2003, European urology.

Centralization of radical prostatectomy in the United States.

D. Penson, C. Anderson, D. Makarov, 2013, The Journal of urology.

Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: study of a US population

I. Thompson, C. Moinpour, S. Ramsey, 2011, International journal of general medicine.

Comparing the Effects of Surgery, Radiation Therapy, and Active Surveillance on Men with Localized Prostate Cancer -- The CEASAR Study

D. Penson, D. Barocas, 2020 .

Creation of a standardized set of patient-centered outcomes for advanced prostate cancer: An international effort.

D. Penson, A. Morgans, C. Stowell, 2015 .

The Power and the Peril of Large Administrative Databases.

D. Penson, 2015, The Journal of urology.

Preliminary treatment considerations among men with newly diagnosed prostate cancer.

I. Thompson, C. Moinpour, S. Ramsey, 2010, The American journal of managed care.

Re: Effectiveness of Primary Androgen-Deprivation Therapy for Clinically Localized Prostate Cancer

D. Penson, 2014 .

An Empiric Evaluation of the Effect of Variation in Intensity of Followup for Surgically Treated Renal Neoplasms on Cancer Specific Survival

Sam S. Chang, D. Penson, D. Barocas, 2017, The Journal of urology.

Outpatient versus Inpatient Observation after Percutaneous Native Kidney Biopsy: A Cost Minimization Study

T. Ikizler, D. Penson, K. Cavanaugh, 2011, American Journal of Nephrology.

Prostate cancer survivorship care guidelines: American Society of Clinical Oncology practice guideline endorsement.

D. Penson, C. Lacchetti, M. Resnick, 2015, Journal of oncology practice.

Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer: Preliminary Experience from a Single Center in a Prospective, Multi-Center, Single-Arm Clinical Trial.

D. Penson, R. Staruch, S. Arora, 2020, Journal of vascular and interventional radiology : JVIR.

Racial variation in the quality of surgical care for prostate cancer.

Sam S. Chang, D. Penson, Michael Cookson, 2012, The Journal of urology.

Prostate cancer on the Internet--information or misinformation?

Peter C Black, D. Penson, P. Black, 2006, The Journal of urology.

Re: Association between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes after 3 Years.

D. Penson, 2017, The Journal of urology.

Comparison of Patient-reported Outcomes After External Beam Radiation Therapy and Combined External Beam With Low-dose-rate Brachytherapy Boost in Men With Localized Prostate Cancer.

Daniel J. Lee, M. Cooperberg, S. Kaplan, 2018, International journal of radiation oncology, biology, physics.

Functional Recovery Following Primary Treatment for Prostate Cancer: Update from the CEASAR Study.

D. Penson, D. Barocas, 2020, European urology focus.

Diabetes mellitus and health‐related quality of life in prostate cancer: 5‐year results from the Prostate Cancer Outcomes Study

J. Stanford, D. Penson, L. V. van de Poll-Franse, 2011, BJU international.

Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1 year after diagnosis: an economic perspective

I. Thompson, C. Moinpour, S. Ramsey, 2013, Supportive Care in Cancer.

Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study

M. Cooperberg, S. Kaplan, S. Greenfield, 2022, The Journal of urology.

Re: higher fees paid to us physicians drive higher spending for physician services compared to other countries.

D. Penson, 2012, The Journal of urology.

MP70-02 TREATMENT PRACTICE PATTERNS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS PRIOR TO RECEIVING SIPULEUCEL-T: DATA FROM PROCEED

M. Cooperberg, A. Armstrong, C. Higano, 2013 .

Patient expectations of benefit from systemic treatments for metastatic prostate cancer

D. Penson, A. Morgans, A. Fought, 2019, Cancer medicine.

Prostate-Specific Antigen Screening for Prostate Cancer: Yes, No, or Maybe?

D. Penson, R. Volk, R. Hoffman, 2020 .

Prostate-Specific Antigen Screening for Prostate Cancer : Yes , No , or Maybe ? Moderated by

D. Penson, R. Volk, R. Hoffman, 2022 .

Discussing quality-of-life issues with a patient newly diagnosed with prostate cancer

J. Gore, D. Penson, M. Litwin, 2006, Nature Clinical Practice Urology.

Laparoscopy and Robotics Biochemical Recurrenceefree Survival After Robotic-assisted Laparoscopic vs Open Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer

Sam S. Chang, D. Penson, Michael Cookson, 2014 .

Overdiagnosis and overtreatment of prostate cancer.

T. Tammela, D. Penson, S. Loeb, 2014, European Urology.

More Judicious Use of Expectant Management for Localized Prostate Cancer during the Last 2 Decades

M. Cooperberg, S. Kaplan, S. Greenfield, 2017, The Journal of urology.

Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen.

S. Taneja, H. Lepor, D. Penson, 1999, The Journal of urology.

Re: Changes in Burnout and Satisfaction with Work-Life Balance in Physicians and the General US Working Population between 2011 and 2014.

D. Penson, 2016, The Journal of urology.

Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy

J. Pinski, E. Klein, D. Penson, 2019, Cancer.

Treatment registry for outcomes in patients with castration-resistant prostate cancer (TRUMPET): a methodology for real-world evidence and research

D. Penson, S. Flanders, D. Lin, 2016, Future oncology.

Re: Trends in National Institutes of Health Funding for Clinical Trials Registered in ClinicalTrials.gov.

D. Penson, 2016, The Journal of urology.

Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.

M. Cooperberg, S. Greenfield, K. Hoffman, 2017, European urology.

Re: Explaining racial differences in prostate cancer mortality.

D. Penson, 2013, The Journal of urology.

Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC): Final PROCEED analysis.

P. Kantoff, M. Cooperberg, P. Schellhammer, 2019, Journal of Clinical Oncology.

Re: Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia

John T. Wei, C. Roehrborn, M. Barry, 2011 .

Re: Exploring the Burden of Inpatient Readmissions after Major Cancer Surgery.

D. Penson, 2015, The Journal of urology.

Canadian Consensus Conference: The FDA decision on the use of 5ARIs.

J. Chin, H. Parnes, E. Klein, 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Successful external validation of a model to predict other cause mortality in localized prostate cancer

P. Scardino, J. Stanford, A. Vickers, 2016, BMC Medicine.

Coping Mechanisms for Financial Toxicity Among Patients With Metastatic Prostate Cancer: A Survey-based Assessment

S. Boorjian, Vidit Sharma, D. Penson, 2023, The Journal of urology.

Health System Perspective on Cost for Delivering a Decision Aid for Prostate Cancer Using Time-driven Activity-based Costing

D. Penson, Jefersson Villatoro, David R. Ho, 2023, Medical Care.

Re: Low-Volume vs High-Volume Centers and Management of Fournier's Gangrene in Washington State.

D. Penson, 2017, The Journal of urology.

Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

P. Kantoff, P. Schellhammer, C. Redfern, 2010, The New England journal of medicine.

Quality of life with advanced metastatic prostate cancer.

D. Penson, M. Resnick, 2012, The Urologic clinics of North America.

Racial variation in the quality of surgical care for prostate cancer.

Sam S. Chang, D. Penson, Michael Cookson, 2012, The Journal of urology.

Early detection of prostate cancer: AUA Guideline.

Kirsten L. Greene, P. Kantoff, L. Holmberg, 2013, The Journal of urology.

Increasing use of observation among men at low risk for prostate cancer mortality.

Sam S. Chang, D. Penson, C. Ritch, 2015, The Journal of urology.

Post-prostatectomy incontinence and pelvic floor muscle training: a defining problem.

D. Penson, 2013, European urology.

Treatment for postprostatectomy incontinence: is this as good as it gets?

D. Penson, 2011, Journal of the American Medical Association (JAMA).

Sexual function outcomes of radiation and androgen deprivation therapy for localized prostate cancer in men with good baseline function

M. Cooperberg, S. Kaplan, S. Greenfield, 2021, Prostate Cancer and Prostatic Diseases.

Influence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapy.

J. Stanford, D. Penson, T. Koyama, 2015, The Journal of urology.

Efficacy of intermittent androgen deprivation therapy vs conventional continuous androgen deprivation therapy for advanced prostate cancer: a meta-analysis.

J. Lynch, D. Penson, S. K. Van Den Eeden, 2013, Urology.

Contemporary prostate cancer radiation therapy in the United States: Patterns of care and compliance with quality measures.

Daniel J. Lee, M. Cooperberg, S. Kaplan, 2018, Practical radiation oncology.

The comparative oncologic effectiveness of available management strategies for clinically localized prostate cancer.

D. Penson, M. Resnick, M. Tyson, 2017, Urologic oncology.

Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years

M. Cooperberg, S. Kaplan, S. Greenfield, 2017, JAMA.

Trends in the treatment of localized prostate cancer using supplemented cancer registry data

D. Penson, D. Deapen, A. Hamilton, 2011, BJU international.

Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions

C. Moinpour, S. Ramsey, D. Penson, 2011, World Journal of Urology.

Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.

P. Carroll, D. Penson, V. Master, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

D. Penson, 2008 .

Effect of the USPSTF Grade D Recommendation against Screening for Prostate Cancer on Incident Prostate Cancer Diagnoses in the United States.

Sam S. Chang, D. Penson, D. Winchester, 2015, The Journal of urology.

P. Carroll, C. Kane, D. Penson, 2006, Urology.

Patterns and predictors of urodynamics use in the United States.

D. Penson, R. Dmochowski, W. Reynolds, 2013, The Journal of urology.

Nationwide trends in mastectomy for early-stage breast cancer.

D. Penson, Y. Shyr, L. Du, 2015, JAMA surgery.

Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients.

Sam S. Chang, T. Morgan, D. Penson, 2012, Urology.

Pelvic organ prolapse (POP) surgery: the evidence for the repairs

D. Penson, R. Dmochowski, A. Gomelsky, 2011, BJU international.

Choledocholithiasis management in rural America: health disparity or health opportunity?

S. Phillips, M. Holzman, W. Nealon, 2011, The Journal of surgical research.

Quality of life after breast cancer diagnosis and survival.

X. Shu, W. Zheng, D. Penson, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.